NIH #5R01CA254036-05
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer
- Amount
- $609K
- Period
- 2021-02-03 → 2027-01-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Pancreatic and Hepatic Oncology Research · Oncology
5 total · 1 active
NIH #5R01CA254036-05
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5R01CA254036-04
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5R01CA254036-03
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2026-06-18
2026-06-18
2026-06-18
2026-06-18
Journal of Clinical Oncology · 2026-05-27
Annals of Surgical Oncology · 2025-12-12 · 5 citations
2025-11-24
2025-11-24
2025-11-24
2025-11-24
2025-11-24
Current Oncology · 2025-11-13 · 4 citations
American Journal of Physiology-Cell Physiology · 2025-11-06 · 1 citations
Gastroenterology · 2025-10-27 · 20 citations
Plant-Based Dietary Index and Risk of Pancreatic Cancer: Findings from a Prospective Cohort Study
Cancer Epidemiology Biomarkers & Prevention · 2025-10-09 · 1 citations
The American Journal of Gastroenterology · 2025-10-01
Clinical Chemistry · 2025-10-01
Diabetologia · 2025-09-24 · 5 citations
Modern Pathology · 2025-08-08 · 5 citations
npj Imaging · 2025-06-10 · 5 citations